COMPOSITION
Each ml contains Ciprofloxacin hydrochloride USP equivalent to Ciprofloxacin 3 mg.
INDICATION
Eye
Ciprocin® Eye/Ear Drops is indicated for the treatment of infections caused
by susceptible strains of the designated microorganisms in the conditions
listed below:
Corneal Ulcers: Pseudomonas aeruginosa, Serratia marcescens, Staphylococcus
aureus, Staphylococcus epidermidis, Streptococcus pneumoniae.
Bacterial Conjunctivitis: Haemophilus influenzae, Staphylococcus aureus,
Staphylococcus epidermidis, Streptococcus pneumoniae.
It is also indicated in the treatment of keratitis, kerato-conjunctivitis,
blepharitis, blepharo-conjunctivitis, dacryocistitis, prophylaxis of ocular
infections due to Neisseria gonorrhea or Chlamydia trachomatis, prevention of
ocular infections after removal of a corneal or physical agent before or after
ocular surgery.
Ear
Otitis externa, acute otitis media, chronic suppurative otitis media. Prophylaxis
in otic surgeries such as mastoid surgery.
DOSAGE AND ADMINISTRATION
Eye
Corneal Ulcers: The recommended dosage regimen for the treatment of
corneal ulcers is two drops into the affected eye every 15 minutes for the first
6 hours and then two drops into the affected eye every 30 minutes for the
remainder of the first day. On the second day, instill 2 drops in the affected eye
hourly. On the third through the fourteenth day, place two drops in the affected
eye every four hours. Treatment may be continued after 14 days if corneal
re-epithelization has not been occurred. Bacterial Conjunctivitis: The recommended dosage regimen for the
treatment of bacterial conjunctivitis is one or two drops instilled into the
conjunctival sac(s) every two hours while awake for two days and one or two
drops every four hours while awake for the next five days.
Ear
For all infections, 2-3 drops every 2-3 hours initially, reducing the frequency of
the instillation with control of infection. Treatment should be continued at least 7 days.
CONTRAINDICATION
Hypersensitivity to quinolone group of antibacterials or any of the components
of the formulation.
PRECAUTION
Prolonged ocular use of Ciprofloxacin may result in overgrowth of non-susceptible
organisms, including fungi. Ciprofloxacin should be discontinued at the first
appearance of a skin rash or any other sign of hypersensitivity reaction.
WARNING
Not for injection into the eyes. Contact lenses should not be worn in presence
of infectious eye diseases.
SIDE EFFECTS
Local burning or discomfort, itching, foreign body sensation, crystalline
precipitates, lid margin crusting, conjunctival hyperemia and a bad taste
following administration. Photophobia and nausea may be reported.
DRUG INTERACTION
Specific drug interaction studies have not been conducted with Ciprofloxacin.
PREGNANCY
Safety in pregnant women has not been established.
Reviews
There are no reviews yet.